. 2012 Aug 31;80(4):1045–1060. doi: 10.3797/scipharm.1206-09
© Thakur et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 3.
Zones of inhibition obtained for different BPO gellified emulsions